Diagnostic procedures by Italian general practitioners in response to lower urinary tract symptoms in male patients: A prospective study

Current Medical Research and Opinion

Volumn 20, Issue 5, 2004, Pages 713-721

  Spatafora, Sebastiano ^a   Canepa, Giorgio ^b   Migliari, Roberto ^c   Rotondo, Salvatore ^d   Mandressi, Alberto ^e   Puppo, Paolo ^f  

^a S MARIA NUOVA HOSPITAL   (Italy)

^b GALLIERA HOSPITAL   (Italy)

^c IRCCS POLICLINICO SAN DONATO   (Italy)

^d Azienda Ospedaliera Papardo   (Italy)

^e Azienda Ospedaliera Busto Arsizio   (Italy)

^f UNIVERSITY OF GENOA   (Italy)

Author keywords

Diagnosis; General practice; LUTS; PRODEST; Referral; Urologic diseases

Indexed keywords

CREATININE; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL PRACTICE; CLINICAL PROTOCOL; COST MINIMIZATION ANALYSIS; CREATININE BLOOD LEVEL; DIAGNOSTIC PROCEDURE; ECHOGRAPHY; EVALUATION; EVIDENCE BASED MEDICINE; GENERAL PRACTITIONER; HUMAN; ITALY; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MEDICAL SPECIALIST; MULTICENTER STUDY; OBSERVATION; PATIENT CARE; PATIENT REFERRAL; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PROSPECTIVE STUDY; PROSTATE HYPERTROPHY; SYMPTOM; URINALYSIS; URINARY TRACT DISEASE; UROFLOWMETRY;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; DIAGNOSTIC TESTS, ROUTINE; FAMILY PRACTICE; HUMANS; ITALY; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PROSPECTIVE STUDIES; REFERRAL AND CONSULTATION; UROLOGIC DISEASES;

EID: 2542477878     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079904125003557     Document Type: Article

References (29)

1. Madersbacher S, Haidinger G, Temml C, Schmidbauer CE Prevalence of lower urinary tract symptoms in Austria as assessed by an open survey of 2096 men. Eur Urol 1998;34:136-41
2. Berges RR, Pientka L, Hofner K, et al. Male lower urinary tract symptoms and related health care seeking in Germany. Eur Urol 2001;39:682-7
3. Sonke GS, Kolman D, de la Rosette JJ, et al. Prevalence of lower urinary symptoms in men and influence on their quality of life: Boxmeer Study [in Dutch] Ned Tijdschr Geneeskd 2000;30(144):2558-63
4. Logie JW, Clifford GM, Farmer RD, Meesen BP. Lower urinary tract symptoms suggestive of benign prostatic obstruction - Triumph: the role of general practice databases. Eur Urol 2001;39 (Suppl 3):42-7
5. Bertaccini A, Vassallo F, Martino F, et al. Symptoms, bothersomeness and quality of life in patients with LUTS suggestive of BPH. Eur Urol 2001;40 (Suppl 1):13-8
6. Vercelli M, Quaglia A, Marani E, Parodi S. Prostate cancer incidence and mortality trends among elderly and adult Europeans. Crit Rev Oncol Hematol 2000;35:133-44
7. IMS agency Italy. Servizio Prescrizioni Mediche, Report. 2000
8. United Nations. World Population Prospects: The 2000 Revision Highlights. February 2001, p. 47-50
9. Chisholm GD, Carne SJ, Fitzpatrick JM, et al. Prostate disease: management options for the primary healthcare team. Report of a working party of the British Prostate Group. Postgrad Med J 1995;71:136-42
10. Klomp ML, Rosmalen CF, Romeijnders AC, et al. Benign prostatic hyperplasia recommendations for transmural care [in Dutch]. Ned Tijdschr Geneeskd 1998;142:2563-8
11. Padilla Leon M, Marchal Escalona C, Caballero Alcantara J, et al. Shared care in benign prostatic hyperplasia. First national experience [in Spanish] Actas Urol Esp. 1998;22:478-83
12. Kirby R, Fitzpatrick J, Kirby M, Fitzpatrick A. Shared care for prostatic diseases, 2nd ed., Oxford: Isis Medical Media Ltd; 2000
13. Jimenez Cruz JF, Rodriguez Vallejo JM, Conejero J, et al. The urologist and prostatic disease. National survey. Members of the Spanish Council on Prostatic Health [in Spanish]. Actas Urol Esp 1996;20:630-5
14. Coeurdacier P, Staerman F, Thoquenne G, et al. General practitioners' approach to urination disorders in men over the age of 50. A survey of 250 physicians in Brittany [in French]. Prog Urol 1996;6:52-9
15. Fawzy A, Fontenot C, Guthrie R, Baudier MM. Practice patterns among primary care physicians in benign prostatic hyperplasia and prostate cancer. Fam Med 1997;29:321-5
16. Bruskewitz R. Management of symptomatic BPH in the US: who is treated and how? Eur Urol 1999;36(Suppl 3):7-13
17. Ewyn GJ, Rix A, Matthews P, Stott NC. Referral for 'prostatism': developing a 'performance indicator' for the threshold between primary and secondary care? Fam Pract 1999; 16:140-2
18. Lukacs B. Management of symptomatic BPH in France: who is treated and how? Eur Urol 1999;36(Suppl 3):14-20
19. McNicholas TA. Management of symptomatic BPH in the UK: who is treated and how? Eur Urol 1999;36(Suppl 3):33-9
20. Roehrborn CG, Bartsch G, Kirby R, et al. Guidelines for the diagnosis and treatment of benign prostatic hyperplasia: a comparative, international overview. Urology 2001;58:642-50
21. de la Rosette JMCH, van der Schoot DKE, Debruyne FMJ. Recent developments in guidelines on benign postatic hyperplasia. Curr Opin Urol 2002;12:3-6
22. American Urological Association. Guideline on the management of benign prostatic hyperplasia (BPH), 2003, available from www.auanet.org/timssnet/products/guidelines/bpf_management [accessed 22 December 2003]
23. De la Rosette J, Alivizatos G, Madersbacher S, et al: Guidelines on benign prostatic hyperplasia. In: EAU Healthcare Office, editor. European Association of Urology Guidelines, update. Arnhem: European Association of Urology; 2002
24. Gattellari M, Young JM, Ward JE. GP and patient predictors of PSA screening in Australian general practice. Fam Pract 2003;20:294-303
25. Anonymous. Prostate-specific antigen (PSA) best practice policy. American Urological Association (AUA). Oncology (Huntington) 2000;14:267-72, 277-8, 280 passim
26. Chatelain C, Denis L, Foo KT, Khoury S, Mc Connell J, editors. Benign prostatic hyperplasia, 5th International Consultation on BPH. Health Publication Ltd; 2001
27. Hood HM, Burgess PA, Holtgrewe HL, et al. Adherence to Agency for Health Care Policy and Research guidelines for benign prostatic hyperplasia. J Urol 1997;158:1417-21
28. Collins MM, Barry MJ, Bin L, et al. Diagnosis and treatment of benign prostatic hyperplasia: practice patterns of primary care physicians. J Gen Intern Med 1997;12:224-9
29. Kim HL, Benson DA, Stem SD, Gerber GS. Practice trends in the management of prostate disease by family practice physicians and general internists: an intemet-based survey. Urology 2002;59:266-71